Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles

Pharmazie

Volumn 64, Issue 7, 2009, Pages 436-439

  Pinarbasli, O ^a   Aktas, Y ^b   Dalkara, T ^a   Andrieux, K ^c   Alonso, M J ^d   Fernandez Megia, E ^d   Novoa Carballal, R ^d   Riguera, R ^d   Couvreur, P ^c   Capan, Yilmaz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c UNIV PARIS SUD   (France)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; FREE RADICAL; MACROGOL; N TERT BUTYL ALPHA PHENYLNITRONE; NANOPARTICLE; NITRONE; OXYGEN RADICAL; SCAVENGER; AMINE OXIDE; EXCIPIENT; MACROGOL DERIVATIVE; PHENYL-N-TERT-BUTYLNITRONE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; MORPHOLOGY; NANOENCAPSULATION; NANOTECHNOLOGY; NEUROPROTECTION; NONHUMAN; PARTICLE SIZE; STROKE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; ELECTROCHEMISTRY;

CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CYCLIC N-OXIDES; DRUG COMPOUNDING; ELECTROCHEMISTRY; EXCIPIENTS; FREE RADICAL SCAVENGERS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 70349256078     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8374     Document Type: Article

References (16)

1. Agnihotri SA, Aminabhavi TM (2004) Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Control Release 96: 245-259.
2. Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P (2005a) Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjugate Chem 16: 1503-1511.
3. Aktas Y, Andrieux K, Alonso MJ, Calvo P, Gursoy RN, Couvreur P, Capan Y (2005b) Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm 298: 378-383.
4. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-poly(ethylene oxide) nanoparticles as protein carriers. J Appl Pol Sci 63: 125-132.
5. Chan TYY, Privat SJ, Narducy KW, Chaplin MD, Waterbury LD (1997) Pharmacokinetics and Bioavailability of N-tert-butyl-alpha-phenyl nitrone in rats and dogs. Proc West Pharmacol Soc 40: 57-59.
6. Dehouck M, Cecchelli R, Green AR, Renftel M, Lundquist S (2002) In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY 059 in normoxic, hypoxic and ischemic conditions. Brain Res 955: 229-235.
7. Green RA, Ashwood T, Odergren T, Jackson, MD (2003) Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol Therap 100: 195-214.
8. Hirano S, Hirochi K, Hayashi K, Mikami T, Tachibana H (1991) Cosmetic and pharmaceutical use of chitin and chitosan. In: Gebelein CG, Dunn RL (Eds.), Cosmetics and Pharmaceutical Applications of Polymers. Plenum Press, New York, pp. 95-104.
9. Janes KA, Calvo P, Alonso MJ (2001) Polysaccharide colloidal nanoparticles as delivery systems for macromolecules. Adv Drug Delivery Rev 47: 83-97.
10. Nakashima M, Niwa M, Iwai T, Uematsu T (1999) Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat. Free Radic Biol Med 26: 722-729.
11. Pinarbasli O, Aktas Y, Capan Y (2007) Development and validation of an analytical method for the determination of PBN from chitosan nanoparticles. In: Senel S, Varum KM, Sumnu MM, Hincal AA (Eds.), Advances in Chitin Science, Alp Ofset, Ankara, Vol X, pp. 370-375.
12. Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ (2000) Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-n-tert-butyl nitrone (PBN). Exp Brain Res 130: 60-66.
13. Shu XZ, Zhu KJ (2002) Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 233: 217-225.
14. Xu Y, Du Y (2003) Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 250: 215-226.
15. Vila A, Sanchez A, Janes K, Behrens I, Kissel T, Vila-Jato JL, Alonso MJ (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm 57: 123-131.
16. Yang Y, Li Q, Shuaib A (2000) Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl- nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Experim Neurol 163: 39-45.